Clin2
NCT07211360Possibly a fitNot yet recruiting

Better imaging for brain tumors with PET/MR scans

Primary and Secondary Brain Tumors

Part of Brain & nervous system, Cancer clinical trials.

This study uses a special type of MRI scan combined with PET imaging to look at brain tumors after treatment. It aims to figure out whether new spots seen on MRI are leftover tumor or treatment effects, which could help guide your next care steps.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
270 people
Ages
18 years to 99 years
Study type
Observational

Who can take part

  • You are between 18 and 99 years old.
  • You have been diagnosed with a brain tumor (either primary or that has spread from another cancer).
  • An MRI after treatment showed a new or suspicious spot that is bigger than one centimeter (about the size of a pea).
  • You are able to have a PET/MRI scan (no pregnancy, no severe allergies to contrast material, and no incompatible metal implants).
  • You are willing to allow the study team to review your medical records for follow-up.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07599917Not yet recruiting
Brain scan study for tumor diagnosis and treatment response

This study uses a special PET scan to look at brain tumors (both new and returning) to help doctors understand them better and see how well treatment is working.

NCT05553899Recruiting
PET-MRI scans for monitoring children’s brain tumor return

This study checks whether a special scan called PET-MRI can better tell if a child’s brain tumor has come back after treatment. It may help doctors decide faster and more accurately when changes seen on regular MRI are true tumor recurrence.

Sheffield, South Yorkshire
NCT04111588Recruiting
PET/MRI scan to assess brain tumors and metastases

This trial tests how well a special PET/MRI scan can help doctors evaluate gliomas and brain metastases. It may help improve diagnosis and treatment planning by comparing scan results with tissue samples or surgery findings.

Bergen
NCT05263466Not yet recruiting
Imaging agent to highlight brain tumours before surgery

This study uses a special imaging agent (called PSMA) that may help doctors see brain tumours more clearly during scans. It aims to find out if this agent can better identify aggressive brain tumours, especially gliomas, before surgery.

London
NCT07567196Recruiting
PET imaging to guide surgery for aggressive brain tumors

This trial tests whether using a special PET scan (a type of imaging that shows tumor activity) during brain tumor surgery helps doctors remove more of the tumor safely. You would have a high-grade glioma (an aggressive brain cancer) and be scheduled for surgery.

Torino, Turin
NCT06667726Recruiting· Phase 2
New PET scan for better brain tumor care

This trial studies a special PET scan called 18F-DOPA PET/CT to see if it can help doctors better manage brain tumors. It may be used before surgery, for radiation planning, or when MRI results are unclear.

Rochester, Minnesota

Hear when a new Primary and Secondary Brain Tumors trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.